OptimizeRx Corp.
OPRX | NASDAQ
$7.62
+$0.06 (+0.79%)
Sep 22, 2026, 1:31 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 109.43M | 92.13M | 71.52M | 62.45M | 61.29M | 43.31M |
Cost of Revenue | 40.16M | 32.75M | 28.62M | 23.48M | 25.65M | 19.21M |
Gross Profit | 69.27M | 59.38M | 42.9M | 38.97M | 35.64M | 24.11M |
Operating Income | 12.06M | -13.71M | -26.4M | -12.29M | 361.1K | -2.14M |
Interest Income | 353K | 329K | 2.19M | 852.3K | 16.98K | 68.58K |
Pretax Income | 6.95M | -19.39M | -25.16M | -11.44M | 378.08K | -2.21M |
Net Income | 5.13M | -20.11M | -17.57M | -11.44M | 378.08K | -2.21M |
Selling & General & Admin | 50.25M | 61.27M | 58.02M | 49.24M | 33.19M | 19.93M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 6.96M | 11.82M | 11.28M | 2.02M | 2.09M | 6.31M |
Operating Expenses | 57.21M | 73.08M | 69.3M | 51.26M | 35.28M | 26.24M |
Interest Expense | 5.29M | 6.16M | 1.45M | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 5.68M | 615.94K |
Cost & Expenses | 97.37M | 105.83M | 97.92M | 74.74M | 60.93M | 45.45M |
Income Tax Expense | 1.82M | 725K | -7.6M | n/a | n/a | n/a |
Shares Outstanding (Basic) | 18.56M | 18.29M | 17.12M | 17.78M | 17.23M | 14.83M |
Shares Outstanding (Diluted) | 19M | 18.29M | 17.12M | 17.78M | 17.69M | 14.83M |
EPS (Basic) | 0.28 | -1.10 | -1.03 | -0.64 | 0.02 | -0.15 |
EPS (Diluted) | 0.27 | -1.10 | -1.03 | -0.64 | 0.02 | -0.15 |
EBITDA | 16.57M | -8.9M | -21.31M | -9.42M | 2.34M | 646.9K |
EBIT | 12.24M | -13.23M | -23.71M | -11.44M | 378.08K | -1.32M |
Depreciation & Amortization | 4.33M | 4.33M | 2.4M | 2.02M | 1.97M | 1.97M |
Add to Watchlist
Select watchlists to add or remove OPRX